Global Pneumonia Therapeutics Market Projected to Reach USD 25.67 Billion by 2026

02-Sep-2020 | Facts and Factors

Findings from Facts and Factors report “Pneumonia Therapeutics Market by Product Type (Drugs (Branded and Generics), Vaccines, and Oxygen Therapy), and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global pneumonia therapeutics market in 2019 was approximately USD 14.99 Billion. The market is expected to grow at a CAGR of 8.00% and is anticipated to reach around USD 25.67 Billion by 2026.

Global Pneumonia Therapeutics Market Size

Request Sample Request Customization Buy Now

Pneumonia is a severe inflammation of the lungs. It can be fatal in some people, particularly the elderly and those with respiratory disorders. COVID-19, a disease caused by a novel coronavirus, can spread to the lungs, causing pneumonia. The disease associated with the new coronavirus was originally referred to as novel coronavirus-infected pneumonia (NCIP). It was renamed COVID-19 by the World Health Organization, short for coronavirus disease in 2019. The ongoing COVID-19 pandemic has a positive impact on the demand patterns in the pneumonia therapeutics industry.

Pneumonia Therapeutics Market Size

Browse the full “Pneumonia Therapeutics Market by Product Type (Drugs (Branded and Generics), Vaccines, and Oxygen Therapy), and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/pneumonia-therapeutics-market-by-product-type-drugs-branded

Increasing numbers of cases are expected to boost the growth of the global market for pneumonia therapy. The global pneumonia therapeutics industry is expected to offer huge opportunities to producers, vendors, and customers around the globe. The growing prevalence of community-acquired pneumonia, particularly among younger individuals, is also a key factor contributing to market growth. Additionally, a Consistent increase in funding opportunities for research for the development of new products is expected to broaden the scope for growth over the coming years.

The global pneumonia therapeutics market is segmented on the basis of product type and region. On the basis of product type, the global pneumonia therapeutics market is divided into drugs, vaccines, and oxygen therapy. The drugs category is further divided as branded and generics. The branded drug category includes Aminopenicillins, Quinolones, Macrolides, B-lactamase inhibitors, Cephalosporins, Tetracyclines, Glycopeptide antibiotics, Carbapenems, and Others. The generic drug category includes Quinolones, Macrolides, and Others.

Based upon the region the global market has been categorized as North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. North America is expected to dominate in the global market in terms of revenue as compared to that of markets in other regions during the forecast period 2020-2026. This is attributed to growing incidences of COVID -19, growth in the geriatric population, increasing multidrug resistance in adults & children that reiterates the need for the development of advanced generation therapeutics in the region. Asia Pacific is anticipated to grow at a significant CAGR in the near future. The growth in the Asia Pacific countries is owing to the increasing occurrence of pneumococcal disease, unmet medical needs, increased antimicrobial tolerance, and increased conditions leading to a compromised immune system in the countries of the Asia Pacific.

Report Scope

Report Attribute

Details

Market Size in 2019

USD 14.99 Billion

Projected Market Size in 2026

USD 25.67 Billion

CAGR Growth Rate

8.00%

Base Year

2019

Forecast Years

2020-2026

Key Market Players

Bayer AG, Lupin Pharmaceuticals, Inc., Abbott, Allergan, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, and Merck & Co., Inc. Key operating players in the global pneumonia therapeutics market are aiming towards the mergers and acquisitions in order to get the competitive edge in the market. For instance, Merck & Co., Inc. and Others

Key Segment

By Product Type, By Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

Key players operating in the pneumonia therapeutics market not restricted to include Bayer AG, Lupin Pharmaceuticals, Inc., Abbott, Allergan, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, and Merck & Co., Inc. Key operating players in the global pneumonia therapeutics market are aiming towards the mergers and acquisitions in order to get the competitive edge in the market. For instance, Merck & Co., Inc. is focusing on the development of the V114 pneumococcal vaccine currently under investigation in phase II trials.

This report segments the pneumonia therapeutics market as follows:

Global Pneumonia Therapeutics Market: By Product Type

  • Drugs
    • Branded
      • Quinolones
      • Aminopenicillins
      • Macrolides
      • B-lactamase inhibitors
      • Cephalosporins
      • Tetracyclines
      • Glycopeptide antibiotics
      • Carbapenems
      • Others
    • Generics
      • Quinolones
      • Macrolides
      • Others
  • Vaccines
  • Oxygen Therapy

Global Pneumonia Therapeutics Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors

A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com


Latest Market Research Reports

report img

Bot Security Market Report 2024 – 2032

[219+ Pages Report] According to Facts and Factors, the global bot security market size was valued at USD 611.2 million in 2023 and is predicted to surpass USD 2,991.80 million by the end of 2032. The bot security industry is expected to grow by a CAGR of 19.30% between 2024 and 2032. Bot Security

Published Date : 19-Apr-2024 | | Category : Technology & Media | Pages : 219 | Format : Read more

Inquiry for Buying Request Sample
report img

Hot Fill Packaging Market Report 2024 – 2032

[217+ Pages Report] According to Facts and Factors,the global hot fill packaging market size was valued at USD 66.05 billion in 2023 and is predicted to surpass USD 99.00 billion by the end of 2032. The hot fill packaging industry is expected to grow by a CAGR of 4.60% between 2024 and 2032. Hot Fi

Published Date : 17-Apr-2024 | | Category : Packaging | Pages : 217 | Format : Read more

Inquiry for Buying Request Sample
report img

Anti-counterfeit Pharmaceutical Packaging Market Report 2024 – 2032

[216+ Pages Report] According to Facts and Factors,the global anti-counterfeit pharmaceutical packaging market size was valued at USD 51.08 billion in 2023 and is predicted to surpass USD 142.78 billion by the end of 2032. The anti-counterfeit pharmaceutical packaging industry is expected to grow b

Published Date : 16-Apr-2024 | | Category : Packaging | Pages : 216 | Format : Read more

Inquiry for Buying Request Sample
report img

Bio Based Detergent Enzymes Market Report 2024 – 2032

[215+ Pages Report] According to Facts and Factors,the global bio-based detergent enzymes market size was valued at USD 6.99 billion in 2023 and is predicted to surpass USD 12.32 billion by the end of 2032. The bio-based detergent enzymes industry is expected to grow by a CAGR of 6.50% between 2024

Published Date : 15-Apr-2024 | | Category : Chemical & Materials | Pages : 215 | Format : Read more

Inquiry for Buying Request Sample
report img

3D Mapping and Modeling Market Report 2024 – 2032

[212+ Pages Report] According to Facts and Factors,the global 3D mapping and modeling market size was valued at USD 5.37 billion in 2023 and is predicted to surpass USD 20.59 billion by the end of 2032. The 3D mapping and modeling industry is expected to grow by a CAGR of 16.10% between 2024 and 20

Published Date : 12-Apr-2024 | | Category : Technology & Media | Pages : 212 | Format : Read more

Inquiry for Buying Request Sample

Why FnF Market Research?

1 Inflallible Methodology

to ensure high-level data integrity, accurate analysis, and impeccable forecasts

2 Analyst Support

for complete satisfaction

3 Customization

on-demand customization of scope of the report to exactly meet your needs

4 Targeted Market View

Targeted market view to provide pertinent information and save time of readers

5 Agile Approach

A faster and efficient way to cater to the needs with continuous iteration